XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 13.94%7.04B | 16.34%1.88B | 12.87%1.76B | 12.12%1.72B | 14.36%1.68B | 15.00%6.18B | 12.76%1.61B | 15.78%1.56B | 16.81%1.53B | 14.84%1.47B |
Operating revenue | 13.94%7.04B | 16.34%1.88B | 12.87%1.76B | 12.12%1.72B | 14.36%1.68B | 15.00%6.18B | 12.76%1.61B | 15.78%1.56B | 16.81%1.53B | 14.84%1.47B |
Cost of revenue | 15.52%2.16B | 21.81%594.8M | 16.23%542.9M | 12.80%523.5M | 10.77%499.7M | 15.54%1.87B | 13.93%488.3M | 14.35%467.1M | 16.23%464.1M | 17.90%451.1M |
Gross profit | 13.26%4.88B | 13.96%1.28B | 11.44%1.22B | 11.83%1.19B | 15.94%1.18B | 14.77%4.31B | 12.26%1.13B | 16.40%1.1B | 17.07%1.07B | 13.53%1.02B |
Operating expense | 12.47%2.88B | 14.37%757.6M | 11.52%725.1M | 10.65%699.1M | 13.29%699.7M | 14.98%2.56B | 12.31%662.4M | 18.52%650.2M | 15.17%631.8M | 14.10%617.6M |
Selling and administrative expenses | 12.47%2.88B | 14.37%757.6M | 11.52%725.1M | 10.65%699.1M | 13.29%699.7M | 14.98%2.56B | 12.31%662.4M | 18.52%650.2M | 15.17%631.8M | 14.10%617.6M |
Operating profit | 14.42%2B | 13.38%524.7M | 11.32%496.6M | 13.53%494.2M | 20.02%481.3M | 14.48%1.75B | 12.19%462.8M | 13.45%446.1M | 19.95%435.3M | 12.67%401M |
Net non-operating interest income expense | -57.38%-259.2M | -41.32%-70.8M | -59.67%-67.7M | -93.97%-67.5M | -42.25%-53.2M | 14.40%-164.7M | 6.88%-50.1M | -2.66%-42.4M | 22.15%-34.8M | 28.90%-37.4M |
Non-operating interest expense | 57.38%259.2M | 41.32%70.8M | 59.67%67.7M | 93.97%67.5M | 42.25%53.2M | -14.40%164.7M | -6.88%50.1M | 2.66%42.4M | -22.15%34.8M | -28.90%37.4M |
Other net income (expense) | 41.21%229.6M | 113.91%136.9M | -1.54%38.3M | -102.22%-1.4M | 1,694.29%55.8M | 424.55%162.6M | 227.24%64M | 980.56%38.9M | 4,961.54%63.2M | -66.67%-3.5M |
Earnings from equity interest | 41.84%234.6M | 111.39%141M | 10.32%37.4M | -101.21%-800K | 4,850.00%57M | --165.4M | --66.7M | --33.9M | --66M | ---1.2M |
Special income (charges) | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -78.57%-5M | -51.85%-4.1M | -82.00%900K | 78.57%-600K | 47.83%-1.2M | 94.41%-2.8M | 94.63%-2.7M | 38.89%5M | -115.38%-2.8M | -9.52%-2.3M |
Income before tax | 12.86%1.97B | 23.94%590.8M | 5.56%467.2M | -8.28%425.3M | 34.38%483.9M | 35.97%1.74B | 54.57%476.7M | 24.50%442.6M | 46.32%463.7M | 19.56%360.1M |
Income tax | 11.53%417.9M | 29.54%128.5M | 2.37%99.3M | -14.12%88.2M | 34.43%101.9M | 26.42%374.7M | 62.36%99.2M | 23.41%97M | 11.75%102.7M | 16.98%75.8M |
Net income | 11.93%1.55B | 18.84%462.3M | 5.96%367.9M | -7.62%337.1M | 34.93%382M | -69.54%1.38B | -79.83%389M | 6.18%347.2M | 35.75%364.9M | -85.99%283.1M |
Net income continuous Operations | 13.22%1.55B | 22.46%462.3M | 6.45%367.9M | -6.62%337.1M | 34.37%382M | 38.84%1.37B | 52.65%377.5M | 24.81%345.6M | 60.44%361M | 20.26%284.3M |
Net income discontinuous operations | --0 | --0 | --0 | --0 | --0 | -99.56%15.8M | -99.32%11.5M | -96.81%1.6M | -91.10%3.9M | -100.07%-1.2M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 11.93%1.55B | 18.84%462.3M | 5.96%367.9M | -7.62%337.1M | 34.93%382M | -69.54%1.38B | -79.83%389M | 6.18%347.2M | 35.75%364.9M | -85.99%283.1M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 11.93%1.55B | 18.84%462.3M | 5.96%367.9M | -7.62%337.1M | 34.93%382M | -69.54%1.38B | -79.83%389M | 6.18%347.2M | 35.75%364.9M | -85.99%283.1M |
Basic earnings per share | 11.48%14.47 | 18.41%4.31 | 5.54%3.43 | -7.89%3.15 | 34.21%3.57 | -69.76%12.98 | -79.98%3.64 | 5.52%3.25 | 34.65%3.42 | -86.10%2.66 |
Diluted earnings per share | 11.33%14.35 | 18.56%4.28 | 5.26%3.4 | -8.24%3.12 | 33.58%3.54 | -69.71%12.89 | -80.01%3.61 | 5.56%3.23 | 34.92%3.4 | -86.01%2.65 |
Dividend per share | 9.89%3 | 9.89%0.75 | 9.89%0.75 | 9.89%0.75 | 9.89%0.75 | 10.08%2.73 | 10.08%0.6825 | 10.08%0.6825 | 10.08%0.6825 | 10.08%0.6825 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |